Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Roche has extended its tender offer period relating to its pending $4.3-billion acquisition of Spark Therapeutics, a Philadelphia-based gene-therapy company, from November 25, 2019 to December 10, 2019. Roche had previously extended the offer...

Novartis has agreed to acquire The Medicines Company, biopharmaceutical company focused on cardiovascular diseases, for $9.7 billion. With the acquisition, Novartis would gain The Medicines Company’s investigational twice-yearly administered...

Alkermes, a developer of treatments for central nervous system diseases and oncology, has completed its acquisition of Rodin Therapeutics, a company developing small molecules for treating neurologic diseases, in deal worth up to $950 million ($100...

A roundup of developments and latest news from China (Dollar Tree), Germany (Bayer), India (Zydus Cadila), and the United States (Entera Bio, Torrent Pharma). China FDA Issues Warning Letter to Retailer Dollar Tree for GMP Violations for OTC...

Merck and Co. has acquired Calporta Therapeutics, a developer of small-molecule agonists for treating Niemann-Pick C disease, a rare genetic disorder characterized by an inability of the body to transport cholesterol and other fatty substances...

Eli Lilly and Company has announced plans to invest $400 million in its manufacturing facilities at its Lilly Technology Center campus in Indianapolis, Indiana. The investment includes enhancements to existing manufacturing facilities that make...

Roche has agreed to acquire Promedior, a Lexington, Massachusetts-based clinical-stage biopharmaceutical company with a portfolio of molecules for treating serious fibrotic diseases, in a deal worth up to $1.4 billion. Under the agreement, Roche...

Novo Nordisk and Dicerna Pharmaceuticals, a biopharmaceutical company specializing in ribonucleic acid interference (RNAi) therapies, have formed a collaboration to discover and develop therapies for treating liver-related cardio-metabolic...

Bristol-Myers Squibb (BMS) has completed its $74-billion acquisition of Celgene following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by...

Lupin a Mumbai, India-based pharmaceutical company, has agreed to sell its entire stake in its Japanese subsidiary, Kyowa Pharmaceutical Industry Co., for JPY 57.4 billion ($527 million) to the private-equity firm, Unison Capital Partners. The...

A roundup of developments and latest news from India (Aurobindo, Biocon) and the US (Cosette Pharmaceuticals). India FDA Issues Form 483 to Aurobindo API Mfg Facilities in India The US Food and Drug Administration (FDA) has issued a Form 483...